Stocktoria

Incannex Healthcare Inc. IXHL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-03-18

Incannex Healthcare Inc. statistics & valuation

Market cap$40.9M
P / B3.1×
Net margin-54517.4%
FCF margin-14559.3%
Return on capital-176.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-153825.00% -54517.40% 2023202320242025
Gross margin (%)
2023202320242025
Operating margin (%)
-250341.70% -27661.60% 2023202320242025
Return on equity (%)
-234.40% -164.60% -350.20% 2023202320242025
Shares outstanding
1.59B 15.9M 17.6M 34.5M 2023202320242025
Net debt ($)
2023202320242025
Share buybacks ($)
2023202320242025
Return on assets (%)
-205.20% -108.30% -229.30% 2023202320242025
Free cash flow margin (%)
-134350.00% -14559.30% 2023202320242025
Debt / equity (×)
2023202320242025
EPS ($)
-$3.32 -$1.15 -$1.35 2023202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2023
Operating margin-27661.6%-250341.7%——
Net margin-54517.4%-153825.0%——
FCF margin-14559.3%-134350.0%——
Return on assets-229.3%-108.3%—-205.2%
Return on equity-350.2%-164.6%—-234.4%
Current ratio2.862.886.709.02

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.